2019 annual financial data
Sutro Biopharma 2019 Operating margin
Direct answer
Operating margin was -129.79%.
Operating income was -55.47M USD and net income was -55.74M USD.
Operating cash flow was -65.02M USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42.74M USD
- Operating income
- -55.47M USD
- Net income
- -55.74M USD
- Operating cash flow
- -65.02M USD